Edward M. Basile, Director at TransMedics Group, Inc. (TMDX), sold 3,500 shares at $80.10 ($280K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $280k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2025-05-29 | $632K | — | Filing → |
| TMDX | SELL | 2025-05-13 | $694K | — | Filing → |
| TMDX | SELL | 2024-11-07 | $1.1M | — | Filing → |